Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Kasey Hutt"'
Autor:
Miyoung Kim, Kibum Jeon, Kasey Hutt, Alyssa M Zlotnicki, Hyo Jung Kim, Jiwon Lee, Han-Sung Kim, Hee Jung Kang, Young Kyung Lee
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253541 (2021)
IntroductionWe assessed the applicability of next-generation sequencing (NGS)-based IGH/IGK clonality testing and analyzed the repertoire of immunoglobulin heavy chain (IGH) or immunoglobulin kappa light chain (IGK) gene usage in Korean patients with
Externí odkaz:
https://doaj.org/article/80888204ee10431d83c540911ac93584
Autor:
Kseniya Petrova-Drus, Mustafa Syed, Wayne Yu, Kasey Hutt, Alyssa M. Zlotnicki, Ying Huang, Monika Kamalska-Cyganik, Lidia Maciag, Meiyi Wang, Yuanyuan G. Ma, Caleb Ho, Christine Moung, Jinjuan Yao, Khedoudja Nafa, Jeeyeon Baik, Chad M. Vanderbilt, Jamal K. Benhamida, Ying Liu, Menglei Zhu, Benjamin Durham, Mark D. Ewalt, Paulo Salazar, Ivelise Rijo, Tessara Baldi, Anthony Mato, Lindsey E. Roeker, Mikhail Roshal, Ahmet Dogan, Maria E. Arcila
Publikováno v:
The Journal of Molecular Diagnostics. 25:352-366
Autor:
Miguel Alcoceba, Kasey Hutt, Carmen Chillón, Ying Huang, María García-Álvarez, Ramón García-Sanz, Jeffrey E. Miller, Cristina Jimenez, Marcos González, María Eugenia Sarasquete, Alejandro Medina, Alberto Orfao, Verónica González-Calle, Norma C. Gutiérrez, Isabel Prieto-Conde, Austin Jacobsen, Edgar Vigil, Noemi Puig, Juan Flores-Montero
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
[Context]: Minimal residual disease (MRD) is a major prognostic factor in multiple myeloma, although validated technologies are limited. [Objective]: To standardize the performance of the LymphoTrack next-generation sequencing (NGS) assays (Invivoscr
Autor:
Malin Hultcrantz, Ola Landgren, Chad M. Vanderbilt, Christine Moung, Caleb Ho, Benjamin Diamond, Meiyi Wang, Ying Liu, Ahmet Dogan, Yuanyuan Ma, Kseniya Petrova-Drus, Jinjuan Yao, Jamal Benhamida, Lidia Maciag, Kasey Hutt, Andrés E. Quesada, Binbin Zheng-Lin, Wayne Yu, Jeffrey E. Miller, Menglei Zhu, Maria E. Arcila, Khedoudja Nafa, Mustafa H Syed, Even H Rustad, Mikhail Roshal, Ying Huang, Qi Gao
Publikováno v:
The Journal of Molecular Diagnostics : JMD
The 2016 International Myeloma Working Group consensus recommendations emphasize high-sensitivity methods for minimal residual disease (MRD) detection, treatment response assessment, and prognostication. Next-generation sequencing (NGS) of IGH gene r
Autor:
Elli Papaemmanuil, Venkata Yellapantula, Kasey Hutt, Sham Mailankody, Malin Hultcrantz, Eivind Coward, Theresia Akhlaghi, David J. Mayman, Minal Patel, Elsa Bernard, Ying Huang, Neha Korde, Aaron D. Viny, Christopher Famulare, Francesco Maura, Davine Hofste op Bruinink, Jeffrey E. Miller, Even H Rustad, Kaitlin M. Carroll, Maria E. Arcila, Caleb Ho, Jonathan J Keats, Dickran Kazandjian, Ola Landgren, Austin Jacobsen, Anders Waage, Kristine Misund
Publikováno v:
Am J Hematol
Minimal residual disease (MRD) tracking, by next generation sequencing of immunoglobulin sequences, is moving towards clinical implementation in multiple myeloma. However, there is only sparse information available to address whether clonal sequences
Autor:
Hee Jung Kang, Kibum Jeon, Kasey Hutt, Mi Young Kim, Young Kyung Lee, Jiwon Lee, Han Sung Kim, Hyo Jung Kim, Alyssa M. Zlotnicki
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0253541 (2021)
PLoS ONE
PLoS ONE
IntroductionWe assessed the applicability of next-generation sequencing (NGS)-basedIGH/IGKclonality testing and analyzed the repertoire of immunoglobulin heavy chain (IGH) or immunoglobulin kappa light chain (IGK) gene usage in Korean patients with m
Autor:
Kasey Hutt, Ying Huang, Anne Fischer, Brad S. Kahl, Fei Wan, Nancy L. Bartlett, Alison J. Moskowitz, Todd A. Fehniger, Katrina Peterson, Amanda F. Cashen, Eric D. Jacobsen, Edgar Vigil, Austin Jacobsen, Neha Mehta-Shah, Steven M. Horwitz, Beth Reagan, Armin Ghobadi, Meredith Olson
Publikováno v:
Blood. 136:30-31
Introduction: Peripheral T-cell lymphomas (PTCL) are a rare subset of non-Hodgkin lymphomas with an overall response rate to CHOP-based therapy of 80% but 5-year survival ranges between 20-40%. (Ellin et al Blood 2014) While response by PET/CT is pro
Autor:
Chad M. Vanderbilt, Christine Moung, Yuanyuan Ma, Jason C. Chang, Ola Landgren, Lidia Maciag, Jeffrey E. Miller, Jin Juan Yao, Caleb Ho, Kseniya Petrova-Drus, Kasey Hutt, Ying Huang, Jamal Benhamida, Khedoudja Nafa, Meiyi Wang, Maria E. Arcila, Mustafa H Syed, Qi Gao, Mikhail Roshal, Wayne Yu, Even H Rustad
Publikováno v:
Blood. 134:3380-3380
Introduction: Next-generation sequencing (NGS)-based IGH clonal rearrangement assays can characterize and subsequently track disease-associated clonal sequences for lymphoid and plasma cell neoplasms, even at very low levels. As IGH PCR primers are u
Publikováno v:
Blood. 126:3868-3868
The standard method to analyze clonality and somatic hypermutation of immunoglobulin genes in B-cell non Hodgkin lymphomas is a multiplex PCR followed by capillary electrophoresis and/or Sanger sequencing. Recently, Next Generation Sequencing (NGS) o
Autor:
Kasey Hutt, Jeffrey E. Miller, Pier Paolo Piccaluga, Anna Gazzola, Michael Klass, Jeff Panganiban, Jordan Thornes, Ying Huang
Publikováno v:
Blood. 124:3317-3317
Introduction: Somatic hypermutation (SHM), an important process that evolved to increase the affinity of immunoglobulin molecules, occurs in the germinal center during B-cell maturation. The presence of SHM, defined as ≥ 2% difference from the germ